IMBiologics
Seongnam
About IMBiologics
IMBiologics is a biotechnology company that develops immunomodulatory antibody drugs for physiological balance.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $30.5M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2023)
- Website: imbiologics.com
- Phone: +82 031 8067 8170
Industries & Categories
Biotechnology, Clinical Trials, Medical
Social Profiles
Canonical: https://fsome.com/organization/imbiologics-111166 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.